New pain block could make kidney stone treatment less painful
NCT ID NCT07177625
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looks at whether a retrolaminar block—a numbing injection near the spine—can reduce pain and improve comfort for people undergoing shock wave treatment for kidney stones. About 90 adults will be divided into three groups: one receiving the block, one receiving standard sedation, and one receiving no extra pain relief. Researchers will measure pain levels and the need for additional pain medication during and after the procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Retrolaminar block (a numbing injection near the spine)
What this could lead to
If it works, this could offer a safer, more effective pain relief option for people undergoing shock wave treatment for kidney stones.
What could go wrong
This is a small, early observational study, so results may not apply to everyone. The block may not reduce pain better than standard care and carries rare risks like infection or bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROLITHIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Elazığ Fethi Sekin City Hospital
Elâzığ, 23100, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••